2020
DOI: 10.1007/s00702-020-02166-2
|View full text |Cite
|
Sign up to set email alerts
|

Bifrontal transcranial direct current stimulation modulates fatigue in multiple sclerosis: a randomized sham-controlled study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
47
0
6

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 25 publications
(56 citation statements)
references
References 48 publications
2
47
0
6
Order By: Relevance
“…These protocols were tested in more than 3000 subjects worldwide with no serious adverse events (SAEs), except for some adverse events (AEs) consisting of slight itching under the electrode, mild redness attributed to neutrally driven vasodilation and seldom-occurring headache, fatigue, and/or nausea [32,35]. tDCS was studied in the context of MS, and its efficacy and safety were reported in the context of neuropathic pain [67,68], tactile sensory deficit [69], and fatigue [40,51,[70][71][72][73][74][75], to cite a few. Based on the above, we believe that this study design (5 consecutive daily sessions, 20 min per session, and current intensity of 2 mA, with the proposed circuit setup) is safe and harmless.…”
Section: Safety and Adverse Event Reportingmentioning
confidence: 99%
“…These protocols were tested in more than 3000 subjects worldwide with no serious adverse events (SAEs), except for some adverse events (AEs) consisting of slight itching under the electrode, mild redness attributed to neutrally driven vasodilation and seldom-occurring headache, fatigue, and/or nausea [32,35]. tDCS was studied in the context of MS, and its efficacy and safety were reported in the context of neuropathic pain [67,68], tactile sensory deficit [69], and fatigue [40,51,[70][71][72][73][74][75], to cite a few. Based on the above, we believe that this study design (5 consecutive daily sessions, 20 min per session, and current intensity of 2 mA, with the proposed circuit setup) is safe and harmless.…”
Section: Safety and Adverse Event Reportingmentioning
confidence: 99%
“…tDCS was well-tolerated and there were no serious adverse effects at any time. tDCS safety and patients' clinical discomfort did not significantly differ according to the stimulation condition ( 30 ).…”
Section: Resultsmentioning
confidence: 97%
“…Right-handed patients (age: 18–75 years), with a definite MS diagnosis [according to 2017 revised McDonald criteria; ( 35 )] and low disability [Expanded Disability Status Scale score (EDSS) <6.5; ( 36 )] took part of the study. They had stable treatments (≥ 1 month) and did not suffer from relapses (During the last 2 months), or other relevant neuropsychiatric diseases [inclusion/exclusion criteria details are reported in Chalah et al ( 30 )]. The local ethics committee approved the study which was conducted in conformity with the declaration of Helsinki.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations